Litigation Details for Value Drug Company v. Allergan Sales, LLC (D. Mass. 2016)
✉ Email this page to a colleague
Value Drug Company v. Allergan Sales, LLC (D. Mass. 2016)
| Docket | ⤷ Subscribe | Date Filed | 2016-08-26 |
| Court | District Court, D. Massachusetts | Date Terminated | 2019-09-05 |
| Cause | 15:2 Antitrust Litigation | Assigned To | Denise Jefferson Casper |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,649,180; 6,893,662; 8,580,302 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Value Drug Company v. Allergan Sales, LLC
The small molecule drugs covered by the patents cited in this case are ⤷ Subscribe and ⤷ Subscribe .
Details for Value Drug Company v. Allergan Sales, LLC (D. Mass. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-06-29 | 1 | by a patent it owns or licensed (in this case, U.S. Patent No. 6,649,180), listing the patent purportedly… Delzicol. 145. U.S. Patent No. 6,649,180 (“the ’180 patent”) covers a cellulose capsule having…listed two patents in the FDA’s Orange Book for Asacol, U.S. Patent No. 5,541,170 (“the ’170 patent”) and … 24 Fe, would soon face the patent cliff, e.g., the expiry of the patent(s) covering a drug followed … Sham Patent Listing and Fraudulent Litigation. Warner Chilcott acquired rights to a patent that claimed | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
